Clinical trials
Phase 4 Glomerulonephritis, IGA trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 10 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Guangdong Provincial People's Hospital | 3 |
| Columbia University | 2 |
| The University of Hong Kong | 2 |
| Yonsei University | 2 |
| A. Manzoni Hospital | 1 |
| Baylor College of Medicine | 1 |
| Calliditas Therapeutics AB | 1 |
| Chen Xiangmei | 1 |
| Chinese University of Hong Kong | 1 |
| Christian Medical College, Vellore, India | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulonephritis, IGA | 31 |
| Proteinuria | 12 |
| Glomerulonephritis | 5 |
| Renal Insufficiency, Chronic | 5 |
| Glomerulonephritis, Membranous | 2 |
| Glomerulosclerosis, Focal Segmental | 2 |
| Kidney Failure, Chronic | 2 |
| Albuminuria | 1 |
| Autoimmune Diseases | 1 |
| Camurati-Engelmann Syndrome | 1 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.